MDWD MediWound 6-K2021MediWound Provides Progress Update on Its EscharEx Clinical
11 Jan 21
Files
SEC
Content Analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
|
|
MDWD 6-K Filings
- 11 Jan 21 MediWound Provides Progress Update on Its EscharEx Clinical
- 10 Nov 20 MediWound Reports Third Quarter 2020 Financial Results
- 28 Oct 20 MediWound Completes Enrollment Stage of its NexoBrid Phase 3 Pediatric Study
- 16 Sep 20 MediWound Announces FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns
Filing View
Search this filing
Table of Contents
Get all this for free
- Email alerts for new filings that match keywords or companies
- Plot, compare & download financial data
- 10-K & 10-Q redlined comparisons
- Advanced filing search & analysis
- Sentiment analysis for financial filings
- Favorites, search history, and more…